Latest Share Chat

REMOVE ADS

Indivior Share News (INDV)

Indivior Information

There is currently no data for INDV

REMOVE ADS

Indivior News

Indivior Drug Perseris Now Available To US Schizophrenia Patients

LONDON (Alliance News) - Indivior PLC on Monday said its extended-release drug Perseris is now available in the US for the treatment of schizophrenia ...

TOP NEWS: Indivior Revenue Down As Competitor Cuts Market Share

LONDON (Alliance News) - Indivior PLC on Thursday said revenue fell in the third quarter of the year due to a temporary loss of market share for its S...

Indivior stays on track in third quarter, awaits court decision

(Sharecast News) - Tighter cost control from Indivior helped offset weaker pricing pressures on its sales of its Suboxone anti-opioid addiction drug i...

UK Earnings, Trading Statements Calendar - Next 7 Days

Friday 26 October GlencoreQ3 ProductionInternational Consolidated Airlines GroupQ3 Bank 1

Indivior expects benefits from new US legislation

(Sharecast News) - Indivior said the US government's new healthcare legislation will make treatment for opioid addiction "more immediately accessible"...

Citi cautious on Indivior until evidence of acceleration to product release

(Sharecast News) - Pharmaceuticals business Indivior had its target price lowered from 350p to 240p by investment bank Citi due to concern that there ...

Monday broker round-up

(Sharecast News) - Volution: Numis upgrades to add with a target price of 216p.

Thursday broker round-up

(Sharecast News) - Restaurant Group: HSBC upgrades to buy with a target price of 370p.